StreetAlpha
13F holdings · Q3 2026

Fcpm III Services B.v.

Naarden, P7 · files as Fcpm III Services B.v.
Know the moment Fcpm III Services B.v. filesYou follow Fcpm III Services B.v. An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 2013410

Fcpm III Services B.v. reported 15 stocks worth $1.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are BRVE (41.6%), NAMS (19.5%) and KRSA (6.6%). Compared with Q2 2026, the fund opened new positions in BRVE, KRSA and TARS, added to MPLT, AURA and CBIO and trimmed VOR, DYN and REPL.

Latest filing: what Fcpm III Services B.v. did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
4 new3 added3 trimmed0 sold outBought about $541M · sold about $32.2M
New 4
Added 3
Trimmed 3
  • REPL−$14.4M−39%
  • VOR−$13.6M−17%
  • DYN−$4.2M−7%
Sold out 0

None

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$1.1B+41.3% vs last quarter
Stocks held154 new · 0 sold out
Top 5 weight79.2%very concentrated
Turnover54%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
BRVE
Braveheart Bio Inc
$441M41.6%21.8MNew position1 of 8
2
NAMS
Newamsterdam Pharma Company
$206M19.5%8.5MNo change8 of 8
3
KRSA
Korsana Biosciences Inc
$70.1M6.6%2.2MNew position1 of 8
4
VOR
Vor Biopharma Inc Com New
$65M6.1%3.4M−712K (−17%)5 of 8
5
DYN
Dyne Therapeutics Inc
$57.8M5.5%3.6M−261K (−7%)8 of 8
6
GALECTO INC
$51.9M4.9%2.4MNo change3 of 8
7
MPLT
Maplight Therapeutics Inc
$45.1M4.3%4.4M+1.2M (+37%)4 of 8
8
AURA
Aura Biosciences Inc
$33M3.1%5.2M+1.2M (+29%)2 of 8
9
CBIO
Crescent Biopharma Inc.
$29.5M2.8%2M+345K (+21%)4 of 8
10
REPL
Replimune Group Inc
$22.8M2.1%1.7M−1.1M (−39%)8 of 8
🔒 5 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Reported value

last 8 quarters
$592MQ4 '24
$414MQ1 '25
$369MQ2 '25
$500MQ3 '25
$763MQ4 '25
$722MQ1 '26
$750MQ2 '26
$1.1BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Fcpm III Services B.v. 13F FAQ

What does Fcpm III Services B.v. own?

Fcpm III Services B.v. reported 15 stocks worth $1.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. The table above lists every position in the filing (the top 10 without an account).

What did Fcpm III Services B.v. buy and sell in Q3 2026?

Compared with Q2 2026: 4 new positions, 3 added to, 3 trimmed and 0 sold out. New positions include BRVE, KRSA and TARS.

When will Fcpm III Services B.v. file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Fcpm III Services B.v.'s portfolio worth?

The Q3 2026 filing reports $1.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.